NCT01986894View on ClinicalTrials.gov

A Phase 1 QT Study in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

October 18, 2013

Primary Completion Date

December 2, 2013

Study Completion Date

December 2, 2013

Conditions
Clinical Pharmacology, Healthy Volunteer Study
Interventions
DRUG

Placebo

Single oral dose of Placebo

DRUG

Pomalidomide

Single oral dose of 4 mg pomalidomide

DRUG

Pomalidomide

Single oral dose of 20 mg pomalidomide

DRUG

Moxifloxacin

Single oral dose of 400 mg moxifloxacin tablet

Trial Locations (1)

78744

PPD Phase I Clinic, Austin

Sponsors

Lead Sponsor

Celgene
All Listed Sponsors
lead

Celgene

INDUSTRY